Drug Development in Wartime: Driving Tomorrow's R&D Decisions with Today's COVID-19 Data
Published: | Updated:
The only way for pharma companies to know where to focus their COVID-19 R&D efforts is for the industry to have access to real-time, real-world evidence of what’s working to keep people alive, write Travis Leonardi and William Kirsh.
